Assessing the pattern electroretinogram as a proxy measure for dopamine in the context of iron deficiency

References

• Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995-2011: a systematic analysis of population-representative data. Lancet Glob Health. 2013;1(1):e16–25.
   PubMed Web of Science ®Google Scholar
• DellaValle DM, Haas JD. Iron status is associated with endurance performance and training in female rowers. Med Sci Sports Exerc. 2012;44(8):1552–9.
   PubMed Web of Science ®Google Scholar
• DellaValle DM, Haas JD. Iron supplementation improves energetic efficiency in iron-depleted female rowers. Med Sci Sports Exerc. 2014;46(6):1204–15.
   PubMed Web of Science ®Google Scholar
• Untoro J, Gross R, Schultink W, Sediaoetama D. The association between BMI and haemoglobin and work productivity among Indonesian female factory workers. Eur J Clin Nutr. 1998;52(2):131–5.
   PubMed Web of Science ®Google Scholar
• Wenger MJ, Murray-Kolb LE, Nevins JEH, Venkatramanan S, Reinhart GA, Wesley A, et al. Consumption of a double-fortified salt affects perceptual, attentional, and mnemonic functioning in women in a randomized controlled trial in India. J Nutr. 2017;147(12):2297–308.
   PubMed Web of Science ®Google Scholar
• Wenger MJ, DellaValle DM, Muuray-Kolb LE, Haas JD. Effect of iron deficiency on simultaneous measures of behavior, brain activity, and energy expenditure in the performance of a cognitive task. Nutr Neurosci. 2019;22(3):196–206.
   PubMed Web of Science ®Google Scholar
• Scott SP, Murray-Kolb LE. Iron status is associated with performance on executive functioning tasks in nonanemic young women. J Nutr. 2016;146(1):30–7.
   PubMed Web of Science ®Google Scholar
• Murray-Kolb LE, Wenger MJ, Scott SP, Rhoten SE, Lung’aho MG, Haas JD. Consumption of iron-biofortified beans positively affects cognitive performance in 18- to 27-year-old Rwandan female college students in an 18-week randomized controlled efficacy trial. J Nutr. 2017. doi: 10.3945/jn.117.255356
   Web of Science ®Google Scholar
• Scott SP, Murray-Kolb LE, Wenger MJ, Udipi SA, Ghugre PS, Boy E, et al. Cognitive performance in Indian school-going adolescents is positively affected by consumption of iron-biofortified pearl millet: a 6-month randomized controlled efficacy trial. J Nutr. 2018;148(9):1462–71.
   PubMed Web of Science ®Google Scholar
• Wenger MJ, Murray Kolb LE, Scott SP, Boy E, Haas JD. Modeling relationships between iron status, behavior, and brain electrophysiology: evidence from a randomized study involving a biofortified grain in Indian adolescents. BMC Public Health. 2022;22(1):1299.
   PubMed Web of Science ®Google Scholar
• Scott SP, De Souza MJ, Koehler K, Murray-Kolb LE. Combined iron deficiency and low aerobic fitness doubly burden academic performance among women attending university. J Nutr. 2017;147(1):104–9.
   PubMed Web of Science ®Google Scholar
• Beard JL, Connor JR. Iron status and neural functioning. Annu Rev Nutr. 2003;23(1):41–58.
   PubMedGoogle Scholar
• Grubić Kezele T, Ćurko-Cofek B. Age-related changes and sex-related differences in brain iron metabolism. Nutrients. 2020;12(9):2601.
   PubMed Web of Science ®Google Scholar
• Youdim M, Green A. Biogenic monoamine metabolism and functional activity in iron-deficient rats: behavioural correlates. In: Ciba Foundation Symposium. Vol. 51; 1977. p. 201–25.
   Google Scholar
• Youdim M, Ben-Shachar D, Ashkenazi R, Yehuda S. Brain iron and dopamine receptor function. Adv Biochem Psychopharmacol. 1983;37:309–21.
   PubMedGoogle Scholar
• Youdim MB, Yehuda S. The neurochemical basis of cognitive deficits induced by brain iron deficiency: involvement of dopamine-opiate system. Cell Mol Biol. 2000;46(3):491–500.
   PubMed Web of Science ®Google Scholar
• Erikson KM, Jones BC, Hess EJ, Zhang Q, Beard JL. Iron deficiency decreases dopamine D1 and D2 receptors in rat brain. Pharmacol Biochem Behav. 2001;69(3):409–18.
   PubMed Web of Science ®Google Scholar
• Unger EL, Bianco LE, Jones BC, Allen RP, Earley CJ. Low brain iron effects and reversibility on striatal dopamine dynamics. Exp Neurol. 2014;261:462–8.
   PubMed Web of Science ®Google Scholar
• Pino J, da Luz M, Antunes HKM, Giampá S, Martins VR, Lee KS. Iron-restricted diet affects brain ferritin levels, dopamine metabolism and cellular prion protein in a region-specific manner. Front Mol Neurosci. 2017;10:1–13.
   PubMed Web of Science ®Google Scholar
• Dichtl S, Haschka D, Nairz M, Seifert M, Volani C, Lutz O, et al. Dopamine promotes cellular iron accumulation and oxidative stress responses in macrophages. Biochem Pharmacol. 2018;148:193–201.
   PubMed Web of Science ®Google Scholar
• Li Y, Kim J, Buckett PD, Böhlke M, Maher TJ, Wessling-Resnick M. Severe postnatal iron deficiency alters emotional behavior and dopamine levels in the prefrontal cortex of young male rats. J Nutr. 2011;141(12):2133–8.
   PubMed Web of Science ®Google Scholar
• Parr A, Larsen B, Calabro F, Tervo-Clemmens B, Luna B. Neuroimaging human dopamine-related neurophysiology across development. In: Dopaminergic system function and dysfunction: experimental approaches. Springer; 2022. p. 299–326.
   Google Scholar
• Marín-Valencia I, Serrano M, Ormazabal A, Pérez-Dueñas B, García-Cazorla A, Campistol J, et al. Biochemical diagnosis of dopaminergic disturbances in paediatric patients: analysis of cerebrospinal fluid homovanillic acid and other biogenic amines. Clin Biochem. 2008;41(16-17):1306–15.
   PubMed Web of Science ®Google Scholar
• Larsen B, Olafsson V, Calabro F, Laymon C, Tervo-Clemmens B, Campbell E, et al. Maturation of the human striatal dopamine system revealed by PET and quantitative MRI. Nat Commun. 2020;11(1):846.
   PubMed Web of Science ®Google Scholar
• Kleven MS, Koek W. Differential effects of direct and indirect dopamine agonists on eye blink rate in cynomolgus monkeys. J Pharmacol Exp Ther. 1996;279(3):1211–9.
   PubMed Web of Science ®Google Scholar
• Slagter HA, Georgopoulou K, Frank MJ. Spontaneous eye blink rate predicts learning from negative, but not positive, outcomes. Neuropsychologia. 2015;71(C):126–32.
   PubMedGoogle Scholar
• Karson CN. Spontaneous eye-blink rates and dopaminergic systems. Brain. 1983;106(3):643–53.
   PubMedGoogle Scholar
• Elsworth JD, Lawrence MS, Roth RH, Taylor JR, Mailman RB, Nichols DE, et al. D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey. J Pharmacol Exp Ther. 1991;259(2):595–600.
   PubMed Web of Science ®Google Scholar
• Bodis-Wollner I. Visual deficits related to dopamine deficiency in experimental animals and Parkinson’s disease patients. Trends Neurosci. 1990;13(7):296–302.
   PubMed Web of Science ®Google Scholar
• Masson G, Mestre D, Blin O. Dopaminergic modulation of visual sensitivity in man. Fundam Clin Pharmacol. 1993;7(8):449–63.
   PubMed Web of Science ®Google Scholar
• Brandies R, Yehuda S. The possible role of retinal dopaminergic system in visual performance. Neurosci Biobehav Rev. 2008;32(4):611–56.
   PubMed Web of Science ®Google Scholar
• Broadway JM, Frank MJ, Cavanagh JF. Dopamine D2 agonist affects visuospatial working memory distractor interference depending on individual differences in baseline working memory span. Cogn Affect Behav Neurosci. 2018;18(3):509–20.
   PubMed Web of Science ®Google Scholar
• Clatworthy PL, Lewis SJ, Brichard L, Hong YT, Izquierdo D, Clark L, et al. Dopamine release in dissociable striatal subregions predicts the different effects of oral methylphenidate on reversal learning and spatial working memory. J Neurosci. 2009;29(15):4690–6.
   PubMed Web of Science ®Google Scholar
• Dodds CM, Clark L, Dove A, Regenthal R, Baumann F, Bullmore E, et al. The dopamine D2 receptor antagonist sulpiride modulates striatal BOLD signal during the manipulation of information in working memory. Psychopharmacology. 2009;207(1):35–45.
   PubMed Web of Science ®Google Scholar
• Frank MJ, Seeberger LC, O’Reilly RC. By carrot or by stick: cognitive reinforcement learning in parkinsonism. Science. 2004;306(5703):1940–3.
   PubMed Web of Science ®Google Scholar
• Frank MJ, O’Reilly RC. A mechanistic account of striatal dopamine function in human cognition: psychopharmacological studies with cabergoline and haloperidol. Behav Neurosci. 2006;120(3):497–517.
   PubMed Web of Science ®Google Scholar
• Wenger MJ, Rhoten SE, Murray-Kolb LE, Scott SP, Boy E, Gahutu JB, et al. Changes in iron status are related to changes in brain activity and behavior in Rwandan female university students: results from a randomized controlled efficacy trial involving iron-biofortified beans. J Nutr. 2019;149(4):687–97.
   PubMed Web of Science ®Google Scholar
• Otero GA, Fernández T, Pliego-Rivero FB, Mendieta GG. Iron therapy substantially restores qEEG maturational lag among iron-deficient anemic infants. Nutr Neurosci. 2019;22(5):363–72.
   PubMed Web of Science ®Google Scholar
• Lozoff B, Armony-Sivan R, Kaciroti N, Jing Y, Golub M, Jacobson SW. Eye-blinking rates are slower in infants with iron-deficiency anemia than in nonanemic iron-deficient or iron-sufficient infants. J Nutr. 2010;140(5):1057–61.
   PubMed Web of Science ®Google Scholar
• Lavoie J, Illiano P, Sotnikova TD, Gainetdinov RR, Beaulieu JM, Hébert M. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Biol Psychiatry. 2014;75(6):479–86.
   PubMed Web of Science ®Google Scholar
• Witkovsky P. Dopamine and retinal function. Doc Ophthalmol. 2004;108:17–39.
   PubMed Web of Science ®Google Scholar
• Harnois C, Di Paolo T. Decreased dopamine in the retinas of patients with Parkinson’s disease. Invest Ophthalmol Vis Sci. 1990;31(11):2473–5.
   PubMed Web of Science ®Google Scholar
• Ortuño-Lizarán I, Sánchez-Sáez X, Lax P, Serrano GE, Beach TG, Adler CH, et al. Dopaminergic retinal cell loss and visual dysfunction in Parkinson disease. Ann Neurol. 2020;88(5):893–906.
   PubMed Web of Science ®Google Scholar
• Langheinrich T, van Elset LT, Lagreze WA, Bach M, Lucking CH, Greenlee MW. Visual contrast response functions in Parkinson’s disease: evidence from electroretinograms, visually evoked potentials and psychophysics. Clin Neurophysiol. 2000;111:66–74.
   PubMed Web of Science ®Google Scholar
• Ikeda H, Head G, Ellis C. Electrophysiological signs of retinal dopamine deficiency in recently diagnosed Parkinson’s disease and a follow up study. Ophthalmic Lit. 1995;4(48):308.
   Google Scholar
• Zar JH. Biostatistical analysis. 4th ed. Upper Saddle River (NJ): Prentice Hall; 1999.
   Google Scholar
• Bradshaw K, Hansen R, Fulton A. Comparison of ERGs recorded with skin and corneal-contact electrodes in normal children and adults. Doc Ophthalmol. 2004;109:43–55.
   PubMed Web of Science ®Google Scholar
• Frank MJ, Seeberger LC, O’reilly RC. By carrot or by stick: cognitive reinforcement learning in Parkinsonism. Science. 2004;306(5703):1940–3.
   PubMed Web of Science ®Google Scholar
• Frank MJ, Scheres A, Sherman SJ. Understanding decision-making deficits in neurological conditions: insights from models of natural action selection. Philos Trans R Soc B Biol Sci. 2007;362(1485):1641–54.
   PubMed Web of Science ®Google Scholar
• Brainard DH. The psychophysics toolbox. Spat Vis. 1997;10:433–6.
   PubMedGoogle Scholar
• Pelli DG. The VideoToolbox software for visual psychophysics: transforming numbers into movies. Spat Vis. 1997;10(4):437–42.
   PubMedGoogle Scholar
• Kleiner M, Brainard D, Pelli D, Ingling A, Murray R, Broussard C. What’s new in Psychtoolbox-3. Perception. 2007;36(14):1.
   Google Scholar
• Bach M, Brigell MG, Hawlina M, Holder GE, Johnson MA, McCulloch DL, et al. ISCEV standard for clinical pattern electroretinography (PERG): 2012 update. Doc Ophthalmol. 2013;126:1–7.
   PubMed Web of Science ®Google Scholar
• Brigell M, Bach M, Barber C, Moskowitz A, Robson J. Guidelines for calibration of stimulus and recording parameters used in clinical electrophysiology of vision. Doc Ophthalmol. 2003;107(2):185–93.
   PubMed Web of Science ®Google Scholar
• Wenger MJ, Rhoten SE. Perceptual learning produces perceptual objects. J Exp Psychol Learn Mem Cogn. 2020;46(3):455–75.
   PubMed Web of Science ®Google Scholar
• Delorme A, Makeig S. EEGLAB: an open source toolbox for analysis of single-trial EEG dynamics including independent component analysis. J Neurosci Methods. 2004;134:9–21.
   PubMed Web of Science ®Google Scholar
• Kleifges K, Bigdely-Shamlo N, Kerick SE, Robbins KA. BLINKER: automated extraction of ocular indices from EEG enabling large-scale analysis. Front Neurosci. 2017;11:12.
   PubMed Web of Science ®Google Scholar
• Pion-Tonachini L. ICLabel tutorial: EEG independent component labeling; 2019. University of California, San Diego: Swartz Center for Computational Neuroscience.
   Google Scholar
• Bays BC, Visscher KM, Le Dantec CC, Seitz AR. Alpha-band EEG activity in perceptual learning. J Vis. 2015;15(10):7–7.
   PubMed Web of Science ®Google Scholar
• Box GE, Cox DR. An analysis of transformations. J R Stat Soc Series B Methodol. 1964:211–52.
   Google Scholar
• Arora A, Lin JJ, Gasperian A, Maldjian J, Stein J, Kahana M, et al. Comparison of logistic regression, support vector machines, and deep learning classifiers for predicting memory encoding success using human intracranial EEG recordings. J Neural Eng. 2018;15(6):066028.
   PubMed Web of Science ®Google Scholar
• Hayes AF. Introduction to mediation, moderation, and conditional process analysis: a regression-based approach. 3rd ed. New York: Guilford Press; 2018.
   Google Scholar
• Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–82.
   PubMed Web of Science ®Google Scholar
• Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr. 2007;85:778–87.
   PubMed Web of Science ®Google Scholar
• Bodis-Wollner I, Marx MS, Mitra S, Bobak P, Mylin L, Yahr M. Visual dysfunction in Parkinson’s disease: loss in spatiotemporal contrast sensitivity. Brain. 1987;110(6):1675–98.
   PubMed Web of Science ®Google Scholar
• Hutton JT, Morris JL, Elias JW. Levodopa improves spatial contrast sensitivity in Parkinson’s disease. Arch Neurol. 1993;50(7):721–4.
   PubMedGoogle Scholar
• Cools R, Barker RA, Sahakian BJ, Robbins TW. Enhanced or impaired cognitive function in Parkinson’s disease as a function of dopaminergic medication and task demands. Cereb Cortex. 2001;11(12):1136–43.
   PubMed Web of Science ®Google Scholar
• Cools R, Altamirano L, D’esposito M. Reversal learning in Parkinson’s disease depends on medication status and outcome valence. Neuropsychologia. 2006;44(10):1663–73.
   PubMed Web of Science ®Google Scholar
• Bacher LF. Factors regulating eye blink rate in young infants. Optom Vis Sci. 2010;87(5):337–43.
   PubMed Web of Science ®Google Scholar
• Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods. 2007;39(2):175–91.
   PubMed Web of Science ®Google Scholar
• Dang LC, Samanez-Larkin GR, Castrellon JJ, Perkins SF, Cowan RL, Newhouse PA, et al. Spontaneous eye blink rate (EBR) is uncorrelated with dopamine D2 receptor availability and unmodulated by dopamine agonism in healthy adults. eNeuro. 2017;4(5).
   PubMed Web of Science ®Google Scholar
• Sescousse G, Ligneul R, van Holst RJ, Janssen LK, de Boer F, Janssen M, et al. Spontaneous eye blink rate and dopamine synthesis capacity: preliminary evidence for an absence of positive correlation. Eur J Neurosci. 2018;47(9):1081–6.
   PubMed Web of Science ®Google Scholar
• van den Bosch R, Hezemans FH, Määttä JI, Hofmans L, Papadopetraki D, Verkes RJ, et al. Evidence for absence of links between striatal dopamine synthesis capacity and working memory capacity, spontaneous eye-blink rate, and trait impulsivity. eLife. 2023;12:e83161.
   PubMed Web of Science ®Google Scholar
• Pereira JB, Kumar A, Hall S, Palmqvist S, Stomrud E, Bali D, et al. DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body disease. Nat Aging. 2023:1–9.
   PubMedGoogle Scholar
• Hadjiconstantinou M, Neff NH. Enhancing aromatic L-amino acid decarboxylase activity: implications for L-DOPA treatment in Parkinson’s disease. CNS Neurosci Ther. 2008;14(4):340–51.
   PubMed Web of Science ®Google Scholar
• Köhnke MD, Wiatr G, Kolb W, Köhnke AM, Schick S, Lutz U, et al. Plasma homovanillic acid: a significant association with alcoholism is independent of a functional polymorphism of the human catechol-O-methyltransferase gene. Neuropsychopharmacology. 2003;28(5):1004–10.
   PubMed Web of Science ®Google Scholar
• Bandopadhyay S, Singh B, Bera NK, Das SK, Nayak CR, Chaudhuri T. Plasma homovanillic acid in delusional disorder: implications for dopamine dysfunction. Neuropsychopharmacology. 2009;7(3):1583–90.
   Google Scholar